GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Offer for Sale

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2181.1000 277.10 (14.55%)

NSE Jul 11, 2025 15:31 PM

New 52W High today

Volume: 15.7M

High volume+gain today

Glenmark Pharmaceuticals Ltd.

10 Jul 2024

2181.10

14.55%

Company Update

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Offer for Sale

BSE India

Offer for sale is attached for reference and record.

More from Glenmark Pharmaceuticals Ltd.

Recommended

Five Interesting Stocks Today - July 11, 2025

The Baseline | 11 Jul 2025, 06:25PM

Market closes lower, Mahindra Logistics to raise Rs 750 crore via rights issue

Trendlyne Marketwatch | 11 Jul 2025, 04:20PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals